Cleared Traditional

K052055 - SMISSON-CARTLEDGE THERMAL INFUSION SYSTEM

K052055 is an FDA 510(k) clearance for SMISSON-CARTLEDGE THERMAL INFUSION SYSTEM, manufactured by Smisson-Cartledge Biomedical, LLC. The device is a Class 2 General Hospital device with product code LGZ cleared through the Traditional 510(k) pathway after a 454-day FDA review.

K052055 · Smisson-Cartledge Biomedical, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2006
Decision
454d
Days
Class 2
Risk

K052055 is an FDA 510(k) clearance for the SMISSON-CARTLEDGE THERMAL INFUSION SYSTEM, MODEL TIS-1200. Classified as Warmer, Thermal, Infusion Fluid (product code LGZ), Class II - Special Controls.

Submitted by Smisson-Cartledge Biomedical, LLC (Alpharetta, US). The FDA issued a Cleared decision on October 26, 2006 after a review of 454 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5725 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Smisson-Cartledge Biomedical, LLC devices

FDA 510(k) Submission Details - K052055

510(k) Number K052055 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 2005
Decision Date October 26, 2006
Days to Decision 454 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
325d slower than avg
Panel avg: 129d · This submission: 454d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LGZ Device Classification - Class 2, Special Controls

Product Code LGZ Warmer, Thermal, Infusion Fluid
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LGZ Warmer, Thermal, Infusion Fluid

All 19
Devices cleared under the same product code (LGZ) and FDA review panel - the closest regulatory comparables to K052055.
AMSCO WARMING CABINET
K110769 · STERIS Corporation · Jun 2011
AMSCO WARMING CABINET
K092823 · STERIS Corporation · Dec 2009
NORMOFLO IRRIGATION FLUID WARMER, MODELS H-1100, H-1129, NORMOFLO IRRIGATION WARMING SET, MODELS, IR-40, IR-500, IR-600,
K072080 · Smiths Medical Asd, Inc. · Jun 2008
COMFORTMATE FLUID WARMING SYSTEM, MODEL # FW-200
K012832 · Nxstage Medical, Inc. · Oct 2001
BT 794-BLOOD/FLUID WARMER
K822098 · Electromedics, Inc. · Aug 1982